MICHELLE MANIAS: Open Payments
NPI 1497240212 · SAFETY HARBOR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,168 in 83 payments from 36 companies in 2025. Trend: 2023 $716 · 2024 $1,929 · 2025 $2,168
Food & beverage: $2,006Education: $163
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $299 |
| Gilead Sciences, Inc. | 6 | $226 |
| PFIZER INC. | 7 | $170 |
| Daiichi Sankyo Inc. | 4 | $104 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| ABBVIE INC. | 4 | $96 |
| GENZYME CORPORATION | 3 | $93 |
| Merck Sharp & Dohme LLC | 4 | $91 |
| Janssen Biotech, Inc. | 4 | $88 |
| Rigel Pharmaceuticals, Inc. | 3 | $82 |
Products named: Trodelvy, IBRANCE, LUTATHERA, KISQALI, KEYTRUDA, TAVALISSE, LIBTAYO, Yescarta.
Industry payments across FL — which companies pay providers there.
